ENTITY
BioNTech

BioNTech (BNTX US)

43
Analysis
Health CareGermany
BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.
more
bullishBioNTech
10 Jul 2024 06:01

BioNTech SE: Expansion into Oncology and Cancer Therapies & Other Major Drivers

BioNTech's First Quarter 2024 Earnings Call highlighted a strategic focus on their late-stage oncology pipeline and continued initiatives...

Logo
265 Views
Share
bullishSK Bioscience
30 Jun 2024 01:51

SK Bioscience (302440 KS): Acquiring Majority Stake in IDT Biologika- A Step Toward ‘Globalization’

SK Bioscience secures 60% stake in IDT Biologika, a global CDMO company with state-of-the-art manufacturing facilities in Germany, for KRW339B...

Logo
460 Views
Share
bullishBioNTech
01 Apr 2024 14:17

BioNTech SE: How Its Strengthened Pipeline & Portfolio Is Changing The Game!

This is our first report on biotechnology major, BioNTech. The company recently reported its fourth quarter and full-year 2023 earnings. BioNTech...

Logo
237 Views
Share
24 Oct 2023 23:09

Hansoh Pharmaceutical (3692 HK): New Licensing Deal Boosts Conviction on Innovative Pipeline Prowess

​Hansoh Pharma will receive an upfront payment of $85M and potential milestone payments of up to $1.485B. The licensed drug candidate is currently...

Logo
615 Views
Share
23 Dec 2022 10:46Syndicated

CX Daily: Why China’s Social Relief Efforts Have Fallen Short

Why China’s social relief efforts have fallen short. Germans will soon be able to access BioNTech shot on mainland, ambassador says. China,...

Logo
706 Views
Share
x